Singapore biotech start-up Mirxes to join Hang Seng Composite Index 3 months after Hong Kong IPO

Sign up now: Get ST’s newsletters delivered to your inbox Mirxes will be one of 17 biotech stocks on the index. SINGAPORE – Local firm Mirxes will be added to Hong Kong's Hang Seng Composite Index (HSCI) on Sept 8, a move expected to boost its visibility and trading liquidity, and marking a rare win for a Singapore biotech company on the global stage. The index, which includes Chinese heavyweights such as e-commerce giant Alibaba and electric vehicle maker BYD, covers about 95 per cent of the total market value of companies listed on the Hong Kong main board. It…